GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » PS Ratio

BDMD (Baird Medical Investment Holdings) PS Ratio : (As of Dec. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Baird Medical Investment Holdings's share price is $1.50. Baird Medical Investment Holdings does not have enough years/quarters to calculate the Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate PS Ratio at this moment.

Good Sign:

Baird Medical Investment Holdings Ltd stock PS Ratio (=1.85) is close to 1-year low of 1.85

The historical rank and industry rank for Baird Medical Investment Holdings's PS Ratio or its related term are showing as below:

BDMD' s PS Ratio Range Over the Past 10 Years
Min: 1.72   Med: 2.95   Max: 4.87
Current: 1.81

During the past 3 years, Baird Medical Investment Holdings's highest PS Ratio was 4.87. The lowest was 1.72. And the median was 2.95.

BDMD's PS Ratio is ranked better than
66.09% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 3.3 vs BDMD: 1.81

Baird Medical Investment Holdings's Revenue per Sharefor the six months ended in Dec. 2023 was $0.89.

Warning Sign:

Baird Medical Investment Holdings Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Baird Medical Investment Holdings was -10.40% per year.

Back to Basics: PS Ratio


Baird Medical Investment Holdings PS Ratio Historical Data

The historical data trend for Baird Medical Investment Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings PS Ratio Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - -

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Dec23
PS Ratio - - -

Competitive Comparison of Baird Medical Investment Holdings's PS Ratio

For the Medical Devices subindustry, Baird Medical Investment Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baird Medical Investment Holdings's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's PS Ratio falls into.



Baird Medical Investment Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Baird Medical Investment Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.50/
=

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Baird Medical Investment Holdings  (NAS:BDMD) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Baird Medical Investment Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Baird Medical Investment Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.